BeyondSpring Inc. (BYSI)
$0.59-3.28%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $24M
- Beta
- 0.42
- P/E (TTM)
- -3.56
- Short % float
- 7.65%
- Days to cover
- 2.5
- SI change
- +7.0%
- 1W
- -7.81%
- 1M
- -21.33%
- vs SPY 1W
- -7.67%
- vs SPY 1M
- -23.84%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 4
- VALUE
- 10
- GROWTH
- 35
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC12.0%
REV YoY-
ROE20.0%
EPS YoY-
ROA-45.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-3.56
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B-0.68
P/FCF-
EV/EBITDA-2.74
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.70
ND/EBITDA-
BETA0.42
Company news
FAQ
- What is LOPJLB’s current signal on BYSI?
- LOPJLB’s latest quantitative signal on BeyondSpring Inc. (BYSI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BYSI in?
- BeyondSpring Inc. (BYSI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does BeyondSpring Inc. (BYSI) do?
- BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding agent. Plinabulin has successfully advanced through Phase III clinical trials for two distinct applications: the prevention of chemotherapy-induced neutropenia, and the treatment of advanced non-s…